Healthcare
Renowned for its excellence in trial work, Kirkland & Ellis LLP has vast experience handling bet-the-company litigation for generic pharmaceutical and manufacturing companies involving complex technical and scientific issues. The practice serves as primary counsel on a wide range of product liability and mass tort matters, including multi-district litigations, class actions, defect/recall investigations, and appeals. Mike Brock is a seasoned litigator based in Washington DC specializing in representing pharma and life sciences companies in product liability and mass torts. In Chicago, trial lawyer Donna Welch spearheads the firm’s representation of Gilead in multiple matters regarding its Covid-19 antiviral drug Veklury – including product liability action related to alleged manufacturing negligence and class action regarding its marketing and promotion. The team saw significant expansion in January 2025 with the addition of Allison Brown, Jessica Davidson, Geoffrey Wyatt, Nina Rose, and Christopher Cox from Skadden, Arps, Slate, Meagher & Flom LLP. Kim Bueno joined the team in May 2025 from King & Spalding LLP.
Legal 500 Editorial commentary
Mentions
Profile
Work Department
Litigation
Position
Kim Bueno is a litigation partner in the Austin office of Kirkland & Ellis LLP. Kim defends clients in jury trials and multidistrict litigation. She is nationally recognized for her work in high-stakes personal injury actions and complex commercial litigation.
Kim is a Fellow of the American College of Trial Lawyers and has been recognized by Chambers USA for Litigation – Trial Lawyers in 2024–2025, Nationwide Product Liability & Mass Torts in 2021–2025 and Texas: Austin & Surrounds – Litigation: General Commercial in 2023–2025.
The Legal 500 United States named her a Leading Lawyer in Product Liability, Mass Tort and Class Action – Defense: Pharmaceutical and Medical Devices in 2024 and 2025, highlighting her high-profile victories in federal and state courts throughout the country.
Content supplied by Kirkland & Ellis LLP
Key clients
- AbbVie Allergan Crown Laboratories Eagle Pharmaceuticals Eli Lilly and Company Gilead Sciences GlaxoSmithKline Haleon Kenvue Ranbaxy Pharmaceuticals Syngenta Torrent Pharmaceuticals TPG Capital